Logo

French Alzheimer Group Awards $124K for Protein Kinase, SELDI Studies

Feb 06, 2006

NEW YORK, Feb. 6 (GenomeWeb News) - The Paris-based Association Internationale pour la Recherche sur la Maladie d'Alzheimer has awarded research grants to two French scientific teams studying Alzheimer's disease, the organization announced today.

 

Jacques Hugon and Guylène Page of the PoitiersMedicalSchool will receive €80,000 ($95,600) over two years. The team will be studying the role of the protein kinase PKR in the pathogenesis of the disease.

 

Sylvain Lehmann of the Montpellier Centre National pour la Recherche Scientifique was awarded a one year grant of €24,000 ($28,700). This team will use SELDI-based proteomics technology to reveal new bloodmarkers, said AIRMA.

Breaking News
The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.